SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 74 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $14,000 | 0.0% | 25,009 | 0.0% | 0.00% | – |
| Q1 2016 | $14,000 | +40.0% | 25,009 | +121.4% | 0.00% | – |
| Q4 2015 | $10,000 | +11.1% | 11,298 | 0.0% | 0.00% | – |
| Q3 2015 | $9,000 | -78.0% | 11,298 | -32.6% | 0.00% | – |
| Q1 2015 | $41,000 | 0.0% | 16,763 | +3.1% | 0.00% | – |
| Q4 2014 | $41,000 | -70.5% | 16,260 | -23.7% | 0.00% | – |
| Q2 2014 | $139,000 | -10.3% | 21,301 | -8.8% | 0.00% | – |
| Q1 2014 | $155,000 | +84.5% | 23,350 | +32.5% | 0.00% | – |
| Q4 2013 | $84,000 | +10.5% | 17,624 | +15.5% | 0.00% | – |
| Q3 2013 | $76,000 | -6.2% | 15,254 | -1.2% | 0.00% | – |
| Q2 2013 | $81,000 | – | 15,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
| GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
| Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
| Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
| ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
| HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
| Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
| Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |